Literature DB >> 8037845

[Treatment of choleriform diarrhea during pregnancy].

P Grados1, C A Battilana.   

Abstract

A retrospective review was conducted of the clinical histories of 43 pregnant women treated for acute diarrheal disease in the emergency ward of the María Auxiliadora Departmental Hospital (HADMA) in Lima, Peru, and 32 of the histories were selected for this study. These 32 patients had been admitted to the cholera treatment unit (CTU) of the HADMA for acute choleraic diarrhea with moderate or severe dehydration. The objective was to analyze the clinical evolution of the patients, their response to isotonic rehydration therapy (0.9% saline solution), and the consequences for their pregnancies. The following variables were examined: age; trimester of pregnancy; heart rate and mean blood pressure (MBP) at admission; number of hours since last normal urination; duration of diarrhea; degree of dehydration; volume of diarrhea and vomiting; volume of saline solution administered in the first 2 hours and in total; volume of multi-electrolyte solution (MES) or oral rehydration salts (ORS) administered from the second to the sixth hour and in total; and hours between admission to the emergency ward and transfer to the cholera treatment unit (EME/CTU). Logistic regression analysis revealed a direct and statistically significant correlation between the time of recovery of diuresis and the EME/CTU (P = 0.001; r = 0.65), as well as between time of recovery of diuresis and the volume of diarrhea in the first 4 hours.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8037845

Source DB:  PubMed          Journal:  Bol Oficina Sanit Panam        ISSN: 0030-0632


  6 in total

Review 1.  Cholera in Pregnancy: A Systematic Review and Meta-Analysis of Fetal, Neonatal, and Maternal Mortality.

Authors:  Nguyen-Toan Tran; Richard Taylor; Annick Antierens; Nelly Staderini
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

2.  Pregnancy Outcomes after a Mass Vaccination Campaign with an Oral Cholera Vaccine in Guinea: A Retrospective Cohort Study.

Authors:  Lise Grout; Isabel Martinez-Pino; Iza Ciglenecki; Sakoba Keita; Alpha Amadou Diallo; Balla Traore; Daloka Delamou; Oumar Toure; Sarala Nicholas; Barbara Rusch; Nelly Staderini; Micaela Serafini; Rebecca F Grais; Francisco J Luquero
Journal:  PLoS Negl Trop Dis       Date:  2015-12-29

3.  Factors Related to Fetal Death in Pregnant Women with Cholera, Haiti, 2011-2014.

Authors:  Erin Schillberg; Cono Ariti; Lindsay Bryson; Rodnie Delva-Senat; Debbie Price; Reynold GrandPierre; Annick Lenglet
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

4.  Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study.

Authors:  Mohammad Ali; Allyson Nelson; Francisco J Luquero; Andrew S Azman; Amanda K Debes; Maurice Mwesawina M'bang'ombe; Linly Seyama; Evans Kachale; Kingsley Zuze; Desire Malichi; Fatima Zulu; Kelias Phiri Msyamboza; Storn Kabuluzi; David A Sack
Journal:  Lancet Infect Dis       Date:  2017-02-02       Impact factor: 25.071

5.  Climate change and the potential effects on maternal and pregnancy outcomes: an assessment of the most vulnerable--the mother, fetus, and newborn child.

Authors:  Charlotta Rylander; Jon Øyvind Odland; Torkjel Manning Sandanger
Journal:  Glob Health Action       Date:  2013-03-11       Impact factor: 2.640

6.  Cholera in pregnancy: outcomes from a specialized cholera treatment unit for pregnant women in Léogâne, Haiti.

Authors:  Iza Ciglenecki; Mathieu Bichet; Javier Tena; Erneau Mondesir; Mathieu Bastard; Nguyen-Toan Tran; Annick Antierens; Nelly Staderini
Journal:  PLoS Negl Trop Dis       Date:  2013-08-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.